PSA vs SEM · rev $4.82B vs P/E 15, rev $1.31B
PSA (PSA) versus Select Medical Holdings (SEM) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Select Medical Holdings (SEM) is a medical care facilities company listed on NYSE.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
Latest reported SEM revenue for 2024-12-31 was $1.31B. Net income was $3.8M. Revenue was up 3.2% from 2024-09-30 to 2024-12-31. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
PSA currently screens at market cap $0. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
Not investment advice. Open the PSA and SEM stock pages for the full models.
Not investment advice.